QualityStocks
  The QualityStocks Daily Newsletter for Monday, Dec. 27th 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

OTCReporter (ADHC)

2.

BullRally (UBRG)

3.

Stock Stars (ILNS)


The QualityStocks Daily

American Power Corp. (AMPW)

PennyTrader Publisher, Penny Stock Explosion, Free Hot Penny Stocks, The Pennystock Picks, Early Bird, and Buzz Stocks reported today on American Power Corp. (AMPW). Small Cap Review, Penny stock Profitz, Epic Stock Picks, The Stock Psycho, Topgun stockpicks, Penny Invest, Stock Egg, Hot OTC, Bull Rally, Cool Penny Stocks, OTC Advisors, Shamrock Stocks reported on the Company as well, and we highlight them also, here at the QualityStocks Daily Newsletter.

Founded in 2008, American Power Corp. is a publicly traded energy company whose shares trade on the OTC Bulletin Board. The Company was established with the focus of acquiring near-term, large-scale coal projects in close proximity to national transportation links. American Power envisions developing their large coal resources to support electricity generation. The Company has their headquarters in Denver, Colorado.

American Power Corp. is a member of the Montana Mining Association. The Company holds approximately 29,000 acres in Judith Basin County, Montana - the PACE Coal Project. The estimated resources in place, based on exploration work conducted by Mobil Oil Co. (now ExxonMobil Corp.), in several independent studies, range from 172 million up to 410+ million tons of high volatile bituminous B coal.

The Coal Rank of the PACE Coal Project is high volatile Bituminous B coal with only 3.16 percent sulfur content. The estimated BTU is 12,924 DAF. Previous exploration included 30 holes drilled and 45 samples extracted over 14,000-acre area within their acreage in 1979 by Mobil Oil Co. (now ExxonMobil). Meanwhile, the Walsh & Associates report estimated the Company’s second lease development area of approximately 15,000 acres to represent a minimum of 150 million additional tons of coal.

The infrastructure in place at PACE includes a federal highway, power lines, and three pipelines running through the property. For transportation access, the Warren Buffett/Berkshire Hathaway-owned Burlington Northern Santa Fe Railway (BNSF) line runs through the Company's property, providing access to national markets and prices.
American Power Corp.'s development strategy is to re-establish coal production by re-engaging the on-site coalmine as soon as possible.

On December 13, 2010, American Power Corp. provided an update on their funding activities during 2010. American Power closed a financing agreement in September 2010 for total gross proceeds of $10 million through a 2.5-year stock issuance agreement with a European institutional investor. The agreement includes a warrant component that could provide an additional $10 million to American Power over the coming years.

During 2010, they received a total of $1.1 million from this institutional investor, of which $500,000 were received in virtue of this financing agreement. The Company still has $9.5 million available under this agreement, which they intend to use to fund their operations in the upcoming years.

American Power Corp. (AMPW) closed Monday's trading session at $1.12, down 2.19%, on 488,441 volume with 279 trades.  The average volume for the last 60 days is 108,077.  The 52-week low/high is $0.605/$1.52.

Cline Mining Corp. (CMK.TO)

We are reporting on Cline Mining Corp. (CMK.TO) today, here at the QualityStocks Daily Newsletter.

Cline Mining Corp. is a Toronto Stock Exchange listed company with their headquarters in Toronto, Ontario. The Company is in the business of acquiring, exploring, and developing mine mineral resource properties to production in Canada, the United States and overseas. They are a growth-oriented mine finder, developer, and operator with an experienced management team. Their strategic international corporate partner and shareholder, Mitsui Matsushima, a Japanese coal miner and conglomerate, which is represented on the Cline Board of Directors, support them.

The Company is developing their Lossan and Lodgepole metallurgical coal mine projects in British Columbia, Canada, with the C.I. 43 101 compliant Reports and feasibility studies completed. The Company has an extensive diamond-drilling program in progress at their Cline Lake gold property in Ontario, Canada.

They also have additional iron ore mineral exploration on extensions and step-out areas at their Bekisopa, Madagascar iron ore properties. They are also engaging in the development of their New Elk metallurgical and thermal coalmine property in Colorado, U.S.A.

Cline Mining Corp. owns the existing New Elk Coal Company LLC coal- property surface assets. This includes the Coal Preparation Plant, silos, buildings, railway right of way, surface real estate, mining equipment, conveyor systems, electrics and coal waste dump all related to the New Elk Coal Company LLC coal Resource properties. The contiguous New Elk coal resource deposits are near the town of Trinidad in Los Animas County, southern Colorado, U.S.A.

The acquisition of the New Elk Surface Assets by Cline is the first stage in their acquisition of all of the coal properties and coal resources of New Elk Coal Company LLC, now proceeding. The New Elk Surface Assets are key in the development of the New Elk coal resources, and fundamental to the Cline plan to bring the New Elk Coal resources into commercial production immediately. Cline Ming Corp. has the right to purchase all of the existing coalmine properties, coal resources and related assets of New Elk Coal Company, and includes a 100-kilometer area of interest.

Cline Mining Corp. owns the Lossan coalmine project in northeastern British Columbia, Canada. The Lossan coal is metallurgical (steel making) coal with two grades. These two grades go by the name coking and pulverized coal injection (PCI). An independent Canadian National Instrument 43 101 Report shows an in-place raw coal resource of 239.6 million tonnes. Lossan is proximate to unit train rail service to year round Ridley Island Pacific international tidewater coal terminal (loading to 240,000 dwt vessels).

The independent engineering Report prepared to Canadian Instrument 43 101 requirements has been prepared and delivered to the Company by Norwest Corporation, an independent engineering and consulting company. Rescan Environmental Services Ltd. undertook the environmental protection input and design contained in the Study. The Study and C.I. 43 101 Report estimates total measured and indicated coal resources at the Lossan Coal Project at 186.1 million tonnes and total additional inferred coal resources at the Lossan Coal Project of 53.5 million tonnes.

On December 23, 2010, Cline Mining Corp. said U.S regulators approved a plan that permits underground workers to drive into and mine coal at their New Elk property in Colorado. They said with the U.S. Mine Safety and Health Administration's (MSHA) approval, it has achieved the targeted start-up of the mine in the fourth quarter of this year, and expects production to increase steadily over the next.

Cline Mining Corp. has a target production rate of 3 million tons of coal per year by the end of 2011. The Company said the plan allows miners to drive into and mine coal from the Apache and Allen coal seams at New Elk. Coal miners have already begun production in the Apache coal seam utilizing underground continuous mining methods, the Company said in a statement.

Cline Mining Corp. (CMK.TO) closed Monday's trading session at $4.21, up 19.60%, on 7,950,359 volume.  The 52-week low/high is $0.33/$4.25.

Environmental Infrastructure Holdings Corp. (EIHC)

Thestockwizards.net reported earlier on Environmental Infrastructure Holdings Corp. (EIHC), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Environmental Infrastructure Holdings Corp, through their subsidiaries (Equisol, LLC), provides equipment solutions for the environmental industry in the United States and internationally. The Company designs, fabricates, and sells equipment systems primarily for water and wastewater applications. Environmental Infrastructure Holdings Corp. has their corporate headquarters in West Conshohocken, Pennsylvania. The Company's shares trade on the OTCBB.

The Company offers complete equipment systems, basic maintenance, repair, and operations components, or spare parts. They also provide installation services, environmental engineering and consulting services, turnkey solutions, repair services, as well as optimization, calibration, and maintenance services.

Environmental Infrastructure Holdings Corp. primarily serves refineries, power plants, engineering firms, and manufacturing facilities, as well as commercial, municipal, and governmental facilities. They also provide plastic powder coatings, including the XIOM 1000 and XIOM 5000 spray guns.

The Company's Equisol, LLC is a unique equipment solutions provider, delivering environmentally friendly products, services, and engineering solutions to their customers. Equisol’s expertise in the environmental industry began in the water and wastewater industry, supplying chemical feed automation equipment for utility systems such as cooling towers, boilers, and waste treatment plants. This is still one of their core competencies. However, they have expanded their portfolio to include monitoring and sampling systems for both air and water, above ground tank and containment.

Through their association with world technology leaders, they are able to supply a wide variety of high quality products and services. Their National Sales and Service Team, with more than 600 man-years of experience in engineering, equipment automation, and industrial construction, and maintenance, uses this expertise to select the most effective solution for their customer's applications.

Equisol, LLC specializes in the water & wastewater industry. Equisol, LLC offers Turnkey Solutions, Service & Repair, Maintenance, 24-hour Environmental Engineering & Consulting services, and Optimization & Calibration. Equisol currently has service and fabrication centers located around the United States.

Equisol's equipment solutions are available as part of a complete Equisol-designed solution, as an individual/independent sale, or offered through an equipment stocking plan. Equisol personnel are prepared to travel both domestically and internationally to provide support for their customers.

For Consulting, they provide on-site system reviews / audits and phone consultation services to answer questions on existing equipment systems. This is to help their customers determine the best available technology for their application needs.

Environmental Infrastructure Holdings Corp. (EIHC) closed Monday's trading session at $0.09, even with yesterday’s close.  The average volume for the last 60 days is 88,075.  The 52-week low/high is $0.008/$0.45.

Jiminex, Inc. (JIM.V)

Today we are highlighting Jiminex, Inc. (JIM.V), here at the QualityStocks Daily Newsletter.

Jiminex, Inc. is a junior mining exploration company that trades on the TSX Venture Exchange. The Company's dedication is to increasing shareholder value by acquiring high quality mining properties, using both standard and innovative exploration technology, creating a public visibility through good investor relations, and excellence in both corporate and exploration management. Jiminex, Inc. has their headquarters in Pass Lake, Ontario.

Jiminex Inc. focuses on the exploration and development of gold deposits in Canada. The Company's current emphasis is on drilling of the Northern Eagle property, Hemlo gold mining area, Ontario and Parres-Parres Two Properties, Snow Lake copper-zinc and gold mining camp, Manitoba. 

The expectation is that drilling will begin soon at the Misehkow River property, Pickle Lake gold area, Ontario property.  Jiminex, Inc. is currently well financed for the diamond drilling on all three properties.

The Company has their Parres and Parres Two Properties near Lalor Lake Discovery at Snow Lake, Manitoba. These properties total 55 square km in area. The Parres property straddles a 4 km stretch along Highway 393 following the mine stratigraphy between the former Stall/Rod copper-zinc and the Osborne copper-zinc mines.

The Lalor Lake gold and copper-zinc deposits were recently discovered by HudBay Minerals Inc. 20 km southwest of the properties in a similar geological environment. The past-producing (1.5 million ounces) New Britannia gold mine is also located approximately 15 km southwest of the properties, also in a similar geological environment. Jiminex, Inc. completed a Mega VTEM35 in February 2010 and a geophysical interpretation in April 2010. The consultants have recommended 12 drill holes totaling 2,200 meters and drilling began on October 17, 2010.

The Northern Eagle property sits close to the 22 million ounce Hemlo gold deposit currently undergoing mining by Barrick Gold Corporation. This property is 44 km in area and represents the best target area in the mining camp in which to locate another Hemlo-style gold deposit. Northern Eagle is essentially untested by drilling below depths that could contain most of the Hemlo-style gold deposit.

Caracle Creek International Consulting Inc. completed an interactive Gocad computer geotechnical data model in March 2010. The model was used to select locations for testing using the Titan 24 geophysical system, which can see down to 1,500 meters or more. Quantec Geoscience completed the survey in August 2010. Quantec recommended 15 holes totaling 8,890 meters to test targets never tested on the property. Drilling began November 7, 2010.

The Company also has their Misehkow River Property near PC Gold Inc. Project in Pickle Lake gold area, Ontario. The Misehkow River property covers a regional iron formation that is favorable as a host for gold deposits in the Pickle Lake gold area. Two blocks of claims total 43.1 square kilometers in area and cover 30 km of iron formation lithology.

The property has notable historical gold assay value drill intercepts of up to 0.362 ounces/ton over 2.2 feet and value/width intercepts of up to 0.11 ounces/ton over 21.0 feet. A high-grade gold intersection (1.26 oz. / 43.1 ft. including 4.04 oz/13.1 ft.) drilled at Pickle Lake by PC Gold highlights the high-grade gold potential for the area.

A VTEM airborne survey done in 2009 underwent interpretation in July 2010. The interpretation indicates 5 target areas on which 16 holes totaling 3,000 meters have been recommended for drilling. The expectation is that drilling will begin soon.
  
Jiminex, Inc.
(JIM.V) closed Monday's trading session at $0.22, down 2.27%, on 36,000 volume.  The 52-week low/high is $0.06/$0.38.

National Holdings Corp. (NHLD)

Today we are reporting on National Holdings Corp. (NHLD), here at the QualityStocks Daily Newsletter.

National Holdings Corporation, through their subsidiaries such as National Securities Corporation, engages in the securities brokerage business in the United States. The Company provides various securities brokerage and investment services to retail and institutional clientele. Founded in 1947, National Holdings Corp. has their headquarters in New York, New York. They also have another headquarters office in Seattle, Washington. They list on the OTC Bulletin Board.

The Company's services include the purchase and sale of stocks, bonds, mutual funds, annuities, and other securities. They also offer corporate finance and investment banking services comprising underwriting the sale of securities to the public and arranging for the private placement of securities with investors.

National also offers financial and corporate advisory services consisting of mergers and acquisitions, project financing, capital structure, and specific financing opportunities. They operate as an underwriter of equity securities in initial and secondary public offerings, as well as provide asset management advisory services to high net worth clients.

Furthermore, the Company offers fixed insurance products, including life insurance, disability insurance, long term care insurance and fixed annuities; and bridge loans and commercial mortgages. National also has experience in working with companies in distressed financial situations.

All transactions receive attention from Senior Corporate and Investment Banking Executives. The Company limits the number of deals transacted each year allowing them to provide individual focus to each client. National's size allows the firm to develop strong, long-lasting relationships with clients.

National Securities Corporation's representatives are primarily independent contractors who operate their business with freedom and flexibility in advising their clients. The Independent platform that the Company provides to the brokers allows them to serve better their clients and themselves.

National Securities has partnered with National Financial Services LLC, Member NYSE/SIPC, a Fidelity Investments ® company and Legent Clearing, LLC Member FINRA/SIPC to clear their securities and provide robust service in the ever-changing technological marketplace. National Financial is a premier clearing firm. They provide National Securities, their registered representatives, and their clients with first class financial products and services. Legent Clearing, LLC provides a secondary clearing arrangement that specializes in global clearing.

National Securities also offers rapid execution for a client's trading and market needs. Their financial experts can assist a client in executing complex market strategies, option hedges, and other financial initiatives to maximize the return on their portfolio.

National Holdings Corp. (NHLD) closed Monday's trading session at $0.26, even with yesterday’s close, on 495 volume with 1 trade.  The average volume for the last 60 days is 37,336.  The 52-week low/high is $0.18/$0.80.

NPS Pharmaceuticals, Inc. (NPSP)

Barchart and Small Cap Network reported earlier on NPS Pharmaceuticals, Inc. (NPSP), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

NPS Pharmaceuticals, Inc. is developing new treatment options for patients with rare gastrointestinal and endocrine disorders. The Company is currently advancing two Phase 3 registration programs. NPS Pharmaceuticals, Inc.'s shares trade on the NASDAQ Global Market. Founded in 1986, the Company has their corporate headquarters in Bedminster, New Jersey.

Teduglutide, a proprietary analog of GLP-2, is undergoing evaluation as GATTEX®. This is in a Phase 3 registration study known as STEPS for parenteral nutrition-dependent short bowel syndrome and is in preclinical development for pediatric indications and chemotherapy-induced gastrointestinal mucositis.

NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is undergoing evaluation in a Phase 3 registration study known as REPLACE as a hormone replacement therapy for hypoparathyroidism. NPS Pharmaceuticals, Inc. complements their proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil Pharmaceutical.

NPS views partnerships as an important component of their corporate strategy. They collaborate to manage risk and accelerate the development and commercialization of their product candidates.

NPS Pharmaceuticals, Inc. currently earns royalties on Amgen’s sales of Sensipar® (cinacalet HCl), Nycomed’s sales of Preotact®, which is their PTH 1-84 that is marketed for the treatment of osteoporosis in the European Union, and Kyowa Kirin’s sales of REGPARA® (cinacalcet HCl) in Japan.  They have also licensed the ex-North American rights to teduglutide to Nycomed and the two companies are collaborating on the STEPS study for short bowel syndrome.

The Company's proprietary portfolio also includes several compounds that are available for out-licensing for areas outside of their proprietary therapeutic and/or geographic focus.  These include PREOS® (parathyroid hormone 1-84 [rDNA origin] injection) for osteoporosis, teduglutide for Crohn’s disease, and glycine reuptake inhibitors and NPSP156 for central nervous system disorders.

Last month, NPS Pharmaceuticals, Inc. announced the appointment of Pedro Granadillo to their Board of Directors. Mr. Granadillo served as Senior Vice President of global manufacturing and human resources at Eli Lilly and Company until 2004 when he retired after 34 years of service. He currently serves as a Director of Dendreon Corporation, Haemonetics Corporation, and Nile Therapeutics and previously served as a Director of Noven Pharmaceuticals and First Indiana Bank.

NPS Pharmaceuticals, Inc. (NPSP) closed Monday's session at $8.02, up 2.82%, on 509,610 volume with 2,678 trades.  The average volume for the last 60 days is 388,883.  The 52-week low/high is $3.10/$7.95.

pSivida Corp. (PSDV)

SmallCap Voice reported recently on pSivida Corp. (PSDV), Greenbackers, OTC Picks did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

pSivida Corp. is a global leader in the development of tiny drug delivery products that undergo administration by implantation, injection, or insertion and provide sustained release of drugs on a controlled and level basis for months or years. The Company uses these systems to develop treatments for serious, unmet, medical needs. pSivida Corp.'s shares trade on the NASDAQ Global Market. Founded in 1987, the Company has their headquarters in Watertown, Massachusetts. pSivida conducts their operations from the United States and from Malvern in the United Kingdom.

The Company's most advanced product candidate, Iluvien®, delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME). DME is a leading cause of vision loss, affecting more than a million people in the United States alone, for which there is currently no FDA-approved drug therapy. Iluvien is licensed to Alimera Sciences, Inc.

pSivida has two products approved by the FDA for sustained release delivery of drug to treat chronic back-of-the-eye diseases. These are Retisert® for the treatment of posterior uveitis and Vitrasert® for the treatment of AIDS-related cytomegalovirus (CMV) retinitis.

The Company has licensed both of these products and the technologies underlying them to Bausch & Lomb Incorporated. pSivida also has a global collaborative research and license agreement with Pfizer Inc. Under this research and license agreement, Pfizer may develop additional ophthalmic products using certain of the Company's technologies.

pSivida Corp.'s intellectual property portfolio consists of more than 50 patent families, more than 100 granted patents, including patents accepted for issuance, and more than 150 patent applications.

On December 23, 2010, pSivida Corp. announced that Alimera Sciences, Inc., pSivida's collaborative partner, received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding their New Drug Application (NDA) for Iluvien®. The FDA issued the CRL to communicate their decision that the NDA cannot be approved in its present form.

The NDA seeks approval to market Iluvien®. The Iluvien® NDA underwent submission to the FDA on June 29, 2010 with safety and efficacy data through month 24 of the FAME Study. The FDA granted the NDA Priority Review status on August 30, 2010.

In the CRL, the FDA asked for analyses of safety and efficacy data through month 36 of the FAME Study. This includes exploratory analyses in addition to those previously submitted in the NDA, to assess further the relative benefits and risks of Iluvien®. Alimera has completed month 36 of the FAME Study and has reported that they are preparing the analyses that the FDA has requested. Alimera also reported that they have requested a meeting with the FDA to clarify the path to regulatory approval. The FDA did not ask for any new clinical studies in the CRL. 

Alimera conducted two Phase 3 pivotal clinical trials (collectively known as the FAME Study) for Iluvien®. These involved 956 patients in sites across the U.S., Canada, Europe, and India to assess the efficacy and safety of Iluvien® with two doses, a high and low dose, for the treatment of DME.

The primary efficacy endpoint for the FAME Study is the difference in the percentage of patients whose best corrected visual acuity improved by 15 or more letters from baseline on the ETDRS eye chart at month 24 between the treatment and control groups. The study concluded in October 2010 with the final patient visit at the three-year data point.

pSivida Corp. (PSDV) closed Monday's trading at $5.19, down 18.40%, on 1,210,778 volume with 3,382 trades.  The average volume for the last 60 days is 130,484.  The 52-week low/high is $3.08/$7.22.

Senesco Technologies Inc. (SNT)

Ceocast News, SmallCap Voice, Stock Traders Chat, HotOTC.com, Cool Penny Stocks, Stock Rich, Stockpalooza, and Stock Stars reported earlier on Senesco Technologies Inc. (SNT), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1964, Senesco Technologies Inc. is leveraging proprietary technology that regulates cell death, or apoptosis. Accelerating apoptosis may have application in treating cancer. Delaying apoptosis may have application in certain inflammatory and ischemic diseases. Senesco Technologies Inc.'s shares trades on the NYSE Amex. The Company has their headquarters in New Brunswick, New Jersey.

Senesco Technologies Inc. bases their platform technology on the identification and characterization of specific genes responsible for plant cell death (senescence) and for programmed cell death in humans (apoptosis). The Company has characterized an important suite of genes that regulate senescence and apoptosis, which are the basis of their technology.

Their research and development have shown that they can precisely target these genes for both Agricultural and Human Health applications. The Company bases their technology on the regulation of these existing genes, not the addition of foreign genes.

They are developing their technologies to address multiple opportunities within the global commercial agriculture industry. This includes extending the shelf life of perishable plant products, producing larger and leafier crops, increasing crop yields and reducing the harmful effects of environmental stresses, like drought.

Senesco Technologies Inc. is also researching applications of their technologies, which may address the many human diseases associated with suppressed or premature apoptosis. This includes cancer, glaucoma, and cardiovascular disease.

The Company is preparing to initiate a human clinical trial in multiple myeloma with their lead therapeutic SNS-01. Senesco also has partnered with leading-edge companies engaged in agricultural biotechnology. They earn research and development fees for applying their gene-regulating platform technology to enhance their partners’ products.

Senesco Technologies Inc.'s technology has shown the ability to enhance a wide variety of crops, which could undergo implementation by multiple licensing partners on a global scale. The Company is researching the feasibility of using their technologies as therapeutics in a variety of human health conditions. They plan to establish a similar licensing network for pharmaceuticals.

The Company believes that their technology could have a competitive advantage in treating apoptotic diseases. This is because their technology regulates apoptosis by controlling all genetic pathways that trigger cell death. By mediating multiple pathways, the maximum benefit is obtainable.

In Agriculture, Senesco presently licenses their technology to agricultural companies capable of incorporating their technology into crops grown for commercial agriculture. Senesco anticipates revenues from these relationships in the form of licensing fees, research and development benchmarks, as well as royalties from enhanced crops.

This commercialization strategy allows the Company to generate revenues at various stages of product development. This is while ensuring that their technology undergoes incorporation into a broad spectrum of crops.

Senesco Technologies Inc. (SNT) closed Monday's trading session at $0.30, up 6.94%, on 2,399,205 volume with 1,451 trades.  The average volume for the last 60 days is 234,535.  The 52-week low/high is $0.22/$0.75.

The QualityStocks Company Corner

True 2 Beauty (TRTB)

The QualityStocks Daily Newsletter would like to spotlight True 2 Beauty (TRTB). Today, True 2 Beauty closed trading at $0.22, up 4.41%, on 165,432 volume with 33 trades.  The average 60-day volume is 222,976 with a 52-week low/high of $1.00/$0.02.

True 2 Beauty's (TRTB) “Libigrow” family of products have made their way to Hollywood’s red carpet. The latest edition of In Touch Magazine features an article citing Britney Spears and boyfriend Jason Trawick as Libigow and Libigirl fans. A link to the article is available at the Libigrow website, www.libigrow.com.

True 2 Beauty (TRTB) is a leading manufacturer and distributor of sexual potency pills and liquid products in the United States, with expansion efforts underway in other parts of the world. The company's line of current products currently include Libigrow (for men), Libigirl (for women), Libiliquid Shots and Libiliquid Relaxation Drinks. Made from only natural ingredients, the products are regarded as the most powerful over the counter herbal sexual and performance supplements available on the market.

In addition to being sold online, Libigrow products are sold throughout the U.S. in convenience stores, liquor stores, smoke shops, vitamin stores, independent grocers, and adult boutique stores, with potential in larger chains such as CVS, Walgreens and GNC to name a few. In fact, a major retail pharmacy chain has begun a regional trial in eight of their stores in southern Florida in preparation for a nationwide roll-out to begin in early 2011 for select Libigrow products – the first step to national expansion within the retail pharmacy chain network.

The company has recruited a trained and highly qualified full-time staff. In addition to their talented and well-seasoned designers, the company employs a team of photographers, web designers, a marketing and advertising director and assistant director, account managers in sales, in-house customer service representatives, a commercial ads designer and editor, and an in-house printing team for all promotional material.

Alex Hbaiu leads the company as CEO, president and director. He published several research articles and findings during his employment at Eli Lily Research Labs where he had the opportunity to work with some of the most talented and educated doctors and scientists in the world. Although founded with very little capital, via Mr. Hbaiu's expert leadership Librigrow has grown to over $10,000,000 in sales via "word of mouth" advertising alone. Disclaimer

True 2 Beauty Blog

True 2 BeautyNews:

True 2 Beauty Inc. Announces Libigrow and Libigirl Featured in Celebrity Gossip Magazine

True 2 Beauty, Inc. and Kretek International, Inc. Form Libigrow Team

True 2 Beauty Signs Balkan Countries License for "LibiGrow" Line of Products

Zentric, Inc. (ZNTR)

The QualityStocks Daily Newsletter would like to spotlight Zentric, Inc. (ZNTR). Today Zentric, Inc.  closed trading at $0.076, up 2.01%, on 20,457 volume with 4 trades. The stock’s average daily volume over the past 60 days 112,274 with a 52-week low/high of $0.012/$1.15.

Zentric, Inc. (ZNTR), an advanced battery technology company, has developed a new and revolutionary battery technology to incorporate high voltage dual electrolytes for higher voltages and power. Through innovation, acquisitions and strategic partnerships, the company aims to accelerate the market applicability of advanced battery technologies as well as storage systems.

Zentric, Inc. (ZNTR) the companies unique battery technology allows specific combinations of key battery components to attain a much higher voltage than traditional lead acid batteries while costing a lot less than lithium-ion batteries. By fitting more energy into the same form factor, the company's technology offers a significant advantage over any existing solution on the market.

The company recently signed a Joint Venture agreement to build and operate a battery manufacturing plant in Jilin Province, China. China's demand for batteries is projected to increase 8.5% annually to reach 282 billion yuan by 2013. The market for high capacity batteries is expected to experience even faster growth, projected to increase 30% annually over the next five years.

The Zentric management team consists of renowned experts from the scientific research community as well as the hybrid and electric battery, automotive and financial industries. Leveraging its cutting-edge battery technology and highly competent management team, Zentric is well positioned to capture a significant share of the burgeoning battery industry. Disclaimer

Zentric, Inc. Blog

Zentric, Inc. News:

SmallCapVoice Exclusive Interview Features Alex Jeff Mak, President and CEO of Zentric, Inc.

Zentric, Inc. Announces Appointment of Raymond Tsang as Director of China Operations

Zentric, Inc. Provides Shareholder Update

Daulton Capital Corp. (DUCP)

The QualityStocks Daily Newsletter would like to spotlight Daulton Capital Corp. (DUCP). Today, Daulton Capital Corp. closed trading at $0.20 on 9,102 volume with 7 trades.  The average 60-day volume is 132,526 with a 52-week low/high of $0.10/$0.75. 

Daulton Capital Corp. (DUCP) is a natural resource finance company focused on precious and base metals as well as oil & gas opportunities. With the primary objective of partnering with major and junior natural resource companies for option/joint venturing projects, Daulton Capital has formed an experienced management team with the expertise necessary to capitalize on the tremendous opportunities available in the natural resource sector today.

Daulton Capital Corp. (DUCP) also aims to acquire resource projects and expand exploration while continuing to seek special situations and unique opportunities in under funded projects within the resource sector. When evaluating these opportunities, Daulton Capital keeps its primary focus on growing shareholder value while limiting investment risk. The company also commits itself to being responsible with integrity, trust and respect for all partners and communities involved.

Daulton Capital Corp. (DUCP) has negotiated an option agreement on two key Gold Projects located in the Yukon Territory, Canada; the Hunker Project, which is located in the heart of the famous Klondike Placer Gold District and the Balarat Project, located in the White Gold District. This newly discovered and internationally recognized area is the same district where Underworld Resource's (TSX.UW) recent drill results incepted grades of 103 meters averaging 3.4 g/t Au.

Both energy related resources such as natural gas and oil as well as precious metals such as gold, silver and copper will play a significant role in the growing demands of the world's economy. Taking into consideration the relative buoyancy of the price of precious metals and energy due to worldwide demand drivers, currency and economic turbulence, the outlook for the price of natural resources is quite favorable as demand continues to increase. Disclaimer

Daulton Capital Blog

Daulton Capital News:

Daulton Capital's Property Located in White Gold District of Yukon, Gathering Interest as Gold Climbs Past $1400 an Ounce

Daulton Capital Establishing Gold Exploration in Region That Favors Investment and Rewards

Daulton Capital's Proximity to Proven Gold Reserves Bodes Well as Precious Metal Prices Hit Record Highs

IDO Security Inc. (IDOI)

The QualityStocks Daily Newsletter would like to spotlight IDO Security Inc. (IDOI). Today, IDO Security Inc. closed trading at $0.0009 on 37,419,516 volume with 99 trades.  The average 60-day volume is 49,137,128 with a 52-week low/high of $0.0004/$0.013.

IDO Security, Inc. (IDOI), headquartered in New York with a subsidiary in Israel, focuses on developing solutions for shoes-on weapons metal detection. The company's flagship product, the patented MagShoe™ system, instantly and accurately detects metal items concealed on or in footwear, ankles or feet without requiring the removal of shoes. Taking only 3-4 seconds to scan, the detection system solves possibly the most problematic issue in the security checkpoint routine.

The MagShoe is produced at the company's main manufacturing facility in Rishon LeZion, Israel where it offers local sales and support via a worldwide network of industry-leading distributors and system integrators. Designed for security and loss prevention at high-security venues and checkpoints, IDO Security's products are currently in use at international airports, cruise lines, government agencies and other locations requiring strong security.

The company's detection systems employ state-of-the-art sensors and algorithms to detect weapons and other controlled metal articles. By providing accurate measurements, the MagShoe solutions keep false alarms at minimum - detecting potentially dangerous items while ignoring metal typically found in footwear such as heels, zippers and ornaments. The advanced technology reduces the number of manual inspections required, allowing personnel to focus on the real threat.

President and Director Michael L. Goldberg guides the direction of the company with an extensive business and legal background spanning more than 30 years. Prior to joining IDO Security, Mr. Goldberg spent 17 years as the Chairman, CEO and one-time President of RX Medical Services, a medical company that owned and operated small rural hospitals, clinical laboratories and MRI/CT centers across the US. He has served on the boards and as a member of audit and compensation committees for a number of public companies.
Disclaimer

IDO Security Inc. (IDOI Blog

IDO Security Inc. News:

IDO Security Receives Letter of Intent From UK Distributor for First Multi-Site Order for New MagShoe 3G(TM) Series

IDO Security Answering Travelers' Outcries Demanding Safer and Less Invasive Security Screening Methods

IDO Security to Exhibit and Train Its Distributors on the New 3G and 3G/4 Models in China

IDO Security, Inc. (IDOI) Rides Wave of Airport Security

The history of airport security is largely a reflection of world and American political relations over the past 80 years. The fact is, aircraft hijackings, sometimes termed skyjackings, have occurred almost since the first days of commercial airline flights. Few people remember, but the very first recorded hijacking of an aircraft took place back in 1930, when Peruvian political activists took over a small aircraft to drop leaflets over Peru. The biggest wave of hijackings began in the 1960s, when anti-Castro Cubans began hijacking planes to flee Cuba. In 1961, when the U.S. broke off relations with Cuba, pro-Castro activists and others began to hijack U.S. planes, diverting them to Cuba. Dozens of hijackings attempts, successful or otherwise, followed, with over 60 at its peak from 1968-1969.

By the early 1970s, the first major attempts to securitize airports, screening passengers and baggage, were put into place, though not before the infamous takeover of a Boeing 727 in 1971 by D.B. Cooper, the only unsolved aircraft hijacking in U.S. history. But U.S. airport security got its biggest boost with 9/11 and the war against terrorism. Since 2001, there has been a continuous move to identify and employ more efficient airport security technologies and procedures, an effort that shows no signs of lessening. Earlier this year, over $1 billion was set aside by the Obama administration for new security technologies, with about $300 million being applied to the screening of passengers.

IDO Security is one of the newest firms riding the airport security wave. The company’s flagship product, called MagShoe™, is a unique system for screening passengers that fills a critical security gap. It provides for the quick and accurate scanning of the foot area of passengers, an area not adequately scanned with current systems, without forcing the user to remove shoes, avoiding one of the major complaints of passengers. The device has already been ordered and used by airports around the world, but is just now piercing the huge U.S. market. The company recently signed a distribution agreement with JEI, Inc., to market MagShoe to government agencies and other U.S. markets, and the system is already being evaluated by the GSA for formal approval.

True 2 Beauty Inc.’s (TRTB) Flagship Products Featured in Celebrity Gossip Magazine

True 2 Beauty Inc.’s “Libigrow” family of products have made their way to Hollywood’s red carpet. The latest edition of In Touch Magazine features an article citing Britney Spears and boyfriend Jason Trawick as Libigow and Libigirl fans. A link to the article is available at the Libigrow website, www.libigrow.com

“Libigrow and Libigirl are making their mark in the lives of even the rich and famous,” stated Zara Hbaiu Director of Media Relations. “It’s great to see our family of products bring excitement, fun, happiness, and lovemaking to people around the world. Libigrow and Libigirl are clearly becoming a must have by everyone from ages 18-45; our motto says it all: ‘Not because you need it, Because you want it.’”

With the recently announced distribution agreement with Kretek International now in place, the Libigrow family of products are anticipated to be in every state within the United States & Canada, exceeding over 40,000 retail outlets. In addition to expanding its distribution network, True 2 Beauty will strive to greatly enhance its direct-to-consumer market through promotions, sweepstakes and contests, and media publications.

The recent media confirmation via the inTouch Weekly article is expected to rapidly increase direct sales to consumers. “Marketing and advertising within this target market is fun and exciting and we are reaching out directly to our consumers to involve them in the direct to consumer growth. The demand for Libigrow products is growing rapidly and True 2 Beauty is working hard to exceed that demand,” says Ms. Hbaiu.

According to the press release, True 2 Beauty’s team is focusing every effort next year on establishing relationships with high profile celebrities to endorse Libigrow family of products. This will result in stronger brand recognition and enhance the company’s reputation within the sexual enhancement industry. The team has taken every measure to increase production capacity to 20 million pills per month while staying well prepared for the demand to exceed supply. They firmly believe in dramatically growing the direct-to-consumer business, adding millions to the bottom line and creating a product known and loved worldwide.

Irvine Sensors (IRSN) Closes First Tranche of Financing; Announces Key Management Appointments

Irvine Sensors Corp., a vision systems company that develops and sells miniaturized infrared and electro-optical cameras and relative products, today announced the closing of its initial $11.4 million of financing, which includes the sale of approximately 51.8 million shares of common stock for approximately $3.6 million ($0.07 per share), and approximately $7.8 million of five-year notes bearing simple interest of 12 percent per annum.

The company said it will work to obtain shareholder authority to increase its capital structure to allow the notes to be converted into common stock, at $0.07 per share. If the company receives shareholder authorization, Irvine Sensors will have the right to force conversion of the notes after two years if its common stock has traded at or above $0.25 per share or more for 30 days.

This tranche of financing is backed by two private equity firms engaged in investments in cyber security, a field in which Irvine Sensors has announced positive third-party test results regarding its EAGLE-10™ high-speed solution. The investors have also committed additional capital to a second tranche of the financing contingent on shareholder approval for the aforementioned increase in capital structure.
In accordance with the financing, Irvine Sensors announced several key executive appointments:

Seth Hamot, the managing member of Roark, Rearden & Hamot, general partner of Costa Brava Partnership III, L.P., the lead investor in the financing, will serve as Irvine Sensors’ new chairman of the board.
Chet White will also serve on the company’s board, as is currently the managing partner of The Griffin Fund, the other institutional investor in the financing.

Irvine Sensors also elected Bill Joll to serve as its new president and CEO. Joll, former president of Velocitude, recently sold to Akamai, and of On2 Technologies, a Google acquisition, will also join Irvine Sensors’ board of directors.

John Carson, a founder of Irvine Sensors, will serve as vice-chairman of the board and chief strategist. Also joining the board is Marcus Williams, former vice president for Business Development at IT solutions company TechTeam Global Inc.; Jay Scollins, CFO at Roark, Rearden & Hamot Capital Management, LLC.; and Scott Reed, a principal of The Griffin Fund.

Hamot said he will work with Joll and Carson to lead Irvine Sensors in a new direction. “Having invested our capital to stabilize the firm, we look forward to immediately building upon Irvine Sensors’ long history of successful innovation. Our objective is to turn these cutting-edge technologies into market leading products, and we want to do so quickly. There is much work to be done, but we believe the company is now able to march ahead without distractions,” Hamot stated.

China Sky One Medical, Inc. (CSKI) Boldly Moves into Raw Materials Production, Secures Prime Herb Cultivation Land in Northeast China

China Sky One Medical, www.cski.com.cn, reported that wholly-owned subsidiary Harbin Tian Di Ren Medical Science and Technology Company (TDR) entered into an agreement with the Heilongjiang Tang Wang He Forest Bureau, whereby TDR gains access to some 74k-acres of prime land for growing herbs/plants.

The 30-year agreement (started Dec. 21 of this year), will allow TDR ample capacity to produce GAP-conformant (Good Agriculture Practice) inputs for both their broad array of over 90 different pharmaceutical products and other objectives. The forested Xiao Xing’an Mountain region, in which the planting area is located, is ideally situated in a national park within Heilongjiang Province. This is a great location for growing the kinds of highly sought-after raw ingredients necessary for high-quality traditional Chinese medicines (TCMs) and other potent health foods.

The Company has projected a strategy to capture significant space in the booming Chinese health food sector and plans to independently produce a series of delicious, high-potency foods. Additionally, raw materials will generate premium revenues via sales to eager third parties.
Chairman and CEO of CSKI, Yan-Qing Liu, cited increased long-term demand, scarcity of choice farmland and recent disasters like the flooding in Southwest China earlier this year, as components in the overall vector of TCM herb prices and TCMs.

This agreement effectively upgrades CSKI to a level within the industry where the Company is able to compete directly with larger producers who have their own capacity for the production of raw materials. With further plans to build an extraction and preparation facility near the planting area, the Company has locked-in terms for rent, avoiding future changes in governmental regulation:

• Total Rent for 30-year period of $40M (RMB270M), or $18/acre per year
• Lowest possible rate as regulated by local authority
• Upfront payment of $36M made to avoid increases and receive the discount

 

Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Reports a Successful Webinar Presentation of the Technologies and Operations of Its Bacterial Identification System

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336